Compounds > tobramycin
Page last updated: 2024-08-23

tobramycin and Infections, Serratia

tobramycin has been researched along with Infections, Serratia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Yates, KA1
Chen, CH; Chen, CL; Chen, JT; Lu, DW; Tai, MC1

Other Studies

2 other study(ies) available for tobramycin and Infections, Serratia

ArticleYear
Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Cornea, 2007, Volume: 26, Issue:5

    Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serratia Infections; Serratia marcescens; Tobramycin

2007
Infectious crystalline keratopathy caused by Serratia marcescens.
    Cornea, 2007, Volume: 26, Issue:8

    Topics: Aged; Amnion; Anti-Bacterial Agents; Combined Modality Therapy; Cornea; Corneal Diseases; Debridement; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluorometholone; Glucocorticoids; Humans; Keratoplasty, Penetrating; Serratia Infections; Serratia marcescens; Tobramycin

2007